About
Cardiosonic develops solutions for transluminal, high-intensity ultrasound ablation. The company's flagship application, the TIVUS high-intensity, directional ultrasound catheter system, enables remote, localized, controlled, and repeatable thermal modulation of the renal vessel wall tissue, to perform safe, therapeutic renal sympathetic denervation by ultrasound ablation for resistant hypertension. The TIVUS system consists of the TIVUS catheter and the TIVUS control console. Ultrasound waves are transmitted from the tip of the TIVUS catheter through the arterial wall to ablate the surrounding renal nerves. Renal nerve ablation resets the body's sympathetic tone/drive and results in blood pressurereduction. The TIVUS console enables the interventionalist to control the parameters (e.g. treatment intensity and duration) of the treatment, which lasts less than 10 minutes.
Funding history · 2 rounds · $8.6M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Cardiosonic's primary focus?
- Cardiosonic develops solutions for transluminal, high-intensity ultrasound ablation, specifically targeting resistant hypertension with its TIVUS system.
- When was Cardiosonic founded?
- Cardiosonic was founded in October 2009.
- What is the operational status of Cardiosonic?
- Cardiosonic is currently inactive, having ceased operations in July 2019.
- What is the TIVUS system developed by Cardiosonic?
- The TIVUS system is a high-intensity, directional ultrasound catheter system designed to perform therapeutic renal sympathetic denervation by ultrasound ablation for resistant hypertension.
- What was Cardiosonic's last known funding round?
- Cardiosonic's last known funding was a Series C round in November 2015, raising $2.5 million.
- When did Cardiosonic receive CE Mark for its TIVUS device?
- Cardiosonic received CE Mark for its TIVUS Ablative Catheter Device on April 22, 2014.
- How many employees did Cardiosonic have?
- Cardiosonic had 31 employees.
- What was the total amount of funding raised by Cardiosonic?
- Cardiosonic raised a total of $8.6 million across its funding rounds.